DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPLICATIONS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, providing promising advancements across different clinical and industrial purposes. With its structural similarity to By natural means derived human serum albumin, OsrHSA delivers a safer, much more reliable alternate for therapeutic